Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Primary Health Care | 49 | 2024 | 4736 | 4.250 |
Why?
|
Spinal Stenosis | 18 | 2020 | 257 | 3.360 |
Why?
|
Early Detection of Cancer | 34 | 2025 | 3236 | 3.010 |
Why?
|
Lumbar Vertebrae | 23 | 2018 | 1873 | 1.930 |
Why?
|
Low Back Pain | 19 | 2023 | 987 | 1.830 |
Why?
|
Sciatica | 17 | 2010 | 96 | 1.800 |
Why?
|
Reminder Systems | 5 | 2024 | 388 | 1.670 |
Why?
|
Atrial Fibrillation | 22 | 2024 | 5189 | 1.580 |
Why?
|
Workers' Compensation | 8 | 2010 | 150 | 1.580 |
Why?
|
Physicians, Primary Care | 9 | 2024 | 622 | 1.330 |
Why?
|
Intermittent Claudication | 4 | 2018 | 300 | 1.130 |
Why?
|
Diskectomy | 10 | 2012 | 201 | 1.080 |
Why?
|
Uterine Cervical Neoplasms | 11 | 2025 | 2047 | 1.000 |
Why?
|
Colorectal Neoplasms | 13 | 2024 | 6942 | 0.950 |
Why?
|
Healthcare Disparities | 9 | 2023 | 3413 | 0.950 |
Why?
|
Mass Screening | 18 | 2024 | 5446 | 0.870 |
Why?
|
Radiculopathy | 4 | 2017 | 205 | 0.850 |
Why?
|
Medical Informatics | 3 | 2016 | 745 | 0.830 |
Why?
|
Electrocardiography | 11 | 2024 | 6404 | 0.800 |
Why?
|
Quality Improvement | 7 | 2018 | 3853 | 0.710 |
Why?
|
Health Communication | 1 | 2023 | 216 | 0.700 |
Why?
|
Mammography | 6 | 2014 | 2423 | 0.680 |
Why?
|
Quality of Health Care | 6 | 2019 | 4300 | 0.680 |
Why?
|
Health Services Needs and Demand | 2 | 2019 | 1406 | 0.680 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 452 | 0.660 |
Why?
|
Anti-Obesity Agents | 1 | 2023 | 242 | 0.650 |
Why?
|
Sickness Impact Profile | 3 | 2005 | 297 | 0.640 |
Why?
|
Massachusetts | 19 | 2024 | 8875 | 0.630 |
Why?
|
Disability Evaluation | 9 | 2010 | 1820 | 0.630 |
Why?
|
Communication Barriers | 2 | 2014 | 418 | 0.630 |
Why?
|
Stroke | 10 | 2024 | 9747 | 0.610 |
Why?
|
Tetrabenazine | 1 | 2018 | 21 | 0.600 |
Why?
|
Back Pain | 2 | 2017 | 544 | 0.590 |
Why?
|
Social Work | 1 | 2019 | 158 | 0.570 |
Why?
|
Middle Aged | 90 | 2025 | 223009 | 0.570 |
Why?
|
Aged | 78 | 2025 | 171117 | 0.560 |
Why?
|
Humans | 178 | 2025 | 765968 | 0.560 |
Why?
|
Health Promotion | 3 | 2019 | 2208 | 0.550 |
Why?
|
Colposcopy | 2 | 2024 | 151 | 0.540 |
Why?
|
Valine | 1 | 2018 | 410 | 0.530 |
Why?
|
Female | 115 | 2025 | 396112 | 0.530 |
Why?
|
Community Health Centers | 4 | 2018 | 469 | 0.530 |
Why?
|
Breast Neoplasms | 9 | 2022 | 21056 | 0.510 |
Why?
|
Patient Acceptance of Health Care | 7 | 2024 | 3230 | 0.510 |
Why?
|
Needs Assessment | 3 | 2018 | 1138 | 0.510 |
Why?
|
Male | 104 | 2024 | 363698 | 0.500 |
Why?
|
Epidemics | 1 | 2021 | 514 | 0.500 |
Why?
|
Chronic Disease | 9 | 2017 | 9347 | 0.500 |
Why?
|
Decompression, Surgical | 2 | 2011 | 603 | 0.490 |
Why?
|
Sinusitis | 4 | 2005 | 995 | 0.490 |
Why?
|
Small-Area Analysis | 2 | 2014 | 51 | 0.480 |
Why?
|
Patient Care Management | 4 | 2015 | 303 | 0.480 |
Why?
|
Vulnerable Populations | 4 | 2015 | 718 | 0.470 |
Why?
|
Health Plan Implementation | 1 | 2017 | 338 | 0.460 |
Why?
|
Neurologic Examination | 1 | 2017 | 912 | 0.460 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13451 | 0.450 |
Why?
|
Colonoscopy | 4 | 2021 | 1406 | 0.440 |
Why?
|
Laminectomy | 3 | 2010 | 226 | 0.440 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 193 | 0.420 |
Why?
|
Electronic Health Records | 9 | 2024 | 4873 | 0.410 |
Why?
|
Cohort Studies | 32 | 2025 | 41649 | 0.410 |
Why?
|
Vaginal Smears | 4 | 2025 | 513 | 0.410 |
Why?
|
Case Management | 2 | 2011 | 277 | 0.400 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2021 | 12240 | 0.400 |
Why?
|
Internet | 2 | 2015 | 3106 | 0.400 |
Why?
|
Internship and Residency | 3 | 2019 | 5946 | 0.400 |
Why?
|
Chiropractic | 2 | 2023 | 39 | 0.400 |
Why?
|
Adult | 70 | 2025 | 223044 | 0.390 |
Why?
|
Risk Assessment | 10 | 2024 | 24282 | 0.390 |
Why?
|
Smoking | 3 | 2019 | 9081 | 0.390 |
Why?
|
Refugees | 3 | 2016 | 614 | 0.390 |
Why?
|
Decision Making | 10 | 2024 | 3965 | 0.390 |
Why?
|
Lidocaine | 1 | 2014 | 550 | 0.370 |
Why?
|
Psychometrics | 3 | 2012 | 3062 | 0.360 |
Why?
|
Community Health Services | 1 | 2015 | 657 | 0.350 |
Why?
|
Information Systems | 1 | 2012 | 400 | 0.350 |
Why?
|
Occupational Diseases | 3 | 2008 | 1456 | 0.330 |
Why?
|
Hypercholesterolemia | 1 | 2017 | 1149 | 0.330 |
Why?
|
Quality of Life | 13 | 2018 | 13462 | 0.330 |
Why?
|
Spinal Fusion | 2 | 2011 | 1302 | 0.320 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39193 | 0.320 |
Why?
|
Patient-Centered Care | 3 | 2018 | 1458 | 0.320 |
Why?
|
Electrocardiography, Ambulatory | 5 | 2024 | 582 | 0.320 |
Why?
|
Physician-Patient Relations | 5 | 2024 | 3278 | 0.310 |
Why?
|
Colonic Neoplasms | 3 | 2023 | 2531 | 0.310 |
Why?
|
Workflow | 1 | 2013 | 862 | 0.300 |
Why?
|
Health Resources | 3 | 2024 | 949 | 0.300 |
Why?
|
Papillomavirus Infections | 4 | 2025 | 1640 | 0.300 |
Why?
|
Physicians, Family | 2 | 2008 | 349 | 0.290 |
Why?
|
Anesthetics, Local | 1 | 2014 | 1015 | 0.290 |
Why?
|
Aged, 80 and over | 25 | 2024 | 59489 | 0.280 |
Why?
|
Prospective Studies | 35 | 2024 | 54802 | 0.280 |
Why?
|
Neoplasms | 6 | 2023 | 22340 | 0.280 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1792 | 0.270 |
Why?
|
Anticoagulants | 4 | 2024 | 4862 | 0.270 |
Why?
|
Health Services Accessibility | 4 | 2019 | 5508 | 0.270 |
Why?
|
Medical Informatics Applications | 1 | 2008 | 180 | 0.270 |
Why?
|
Hypertension | 7 | 2019 | 8626 | 0.270 |
Why?
|
Community-Acquired Infections | 4 | 2001 | 470 | 0.270 |
Why?
|
Manipulation, Orthopedic | 2 | 1996 | 40 | 0.270 |
Why?
|
Severity of Illness Index | 7 | 2017 | 15880 | 0.260 |
Why?
|
Guideline Adherence | 8 | 2025 | 2243 | 0.260 |
Why?
|
Socioeconomic Factors | 8 | 2019 | 7838 | 0.250 |
Why?
|
Analgesics, Opioid | 3 | 2018 | 3835 | 0.250 |
Why?
|
Data Collection | 2 | 2014 | 3318 | 0.250 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1662 | 0.240 |
Why?
|
Cardiovascular Diseases | 5 | 2019 | 15652 | 0.240 |
Why?
|
Exercise Therapy | 2 | 2017 | 937 | 0.240 |
Why?
|
Glucocorticoids | 1 | 2014 | 2132 | 0.240 |
Why?
|
Mobility Limitation | 2 | 2020 | 408 | 0.230 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 3110 | 0.230 |
Why?
|
Managed Care Programs | 2 | 2009 | 934 | 0.230 |
Why?
|
Osteoarthritis, Hip | 2 | 2020 | 408 | 0.230 |
Why?
|
Program Evaluation | 4 | 2017 | 2499 | 0.230 |
Why?
|
Population Surveillance | 2 | 2018 | 2590 | 0.220 |
Why?
|
Drug Costs | 3 | 2021 | 1193 | 0.220 |
Why?
|
Decision Support Techniques | 4 | 2018 | 2003 | 0.220 |
Why?
|
Affective Symptoms | 1 | 2006 | 417 | 0.220 |
Why?
|
Health Services Research | 3 | 2017 | 1808 | 0.220 |
Why?
|
Pharyngitis | 1 | 2005 | 221 | 0.220 |
Why?
|
Ambulatory Care Facilities | 1 | 2010 | 939 | 0.220 |
Why?
|
Maine | 7 | 2024 | 146 | 0.220 |
Why?
|
Treatment Outcome | 29 | 2022 | 65188 | 0.210 |
Why?
|
Time Factors | 14 | 2023 | 40065 | 0.210 |
Why?
|
Practice Guidelines as Topic | 10 | 2025 | 7425 | 0.210 |
Why?
|
Natural Language Processing | 2 | 2022 | 1203 | 0.210 |
Why?
|
Physicians | 5 | 2023 | 4588 | 0.210 |
Why?
|
Streptococcal Infections | 2 | 2005 | 617 | 0.210 |
Why?
|
Patient Satisfaction | 10 | 2018 | 3475 | 0.200 |
Why?
|
Alcoholism | 1 | 2013 | 1975 | 0.200 |
Why?
|
Food Supply | 2 | 2018 | 544 | 0.200 |
Why?
|
Internal Medicine | 1 | 2010 | 1064 | 0.200 |
Why?
|
Spinal Diseases | 2 | 2018 | 559 | 0.200 |
Why?
|
Cultural Characteristics | 2 | 2014 | 250 | 0.200 |
Why?
|
Evidence-Based Medicine | 6 | 2020 | 3685 | 0.190 |
Why?
|
Retrospective Studies | 19 | 2021 | 81514 | 0.190 |
Why?
|
Algorithms | 11 | 2023 | 14071 | 0.190 |
Why?
|
BCG Vaccine | 2 | 2022 | 380 | 0.190 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 4416 | 0.190 |
Why?
|
Referral and Consultation | 1 | 2014 | 3615 | 0.190 |
Why?
|
Interviews as Topic | 3 | 2018 | 2739 | 0.180 |
Why?
|
Sigmoidoscopy | 1 | 2001 | 150 | 0.180 |
Why?
|
Obesity | 2 | 2023 | 13076 | 0.180 |
Why?
|
Software Validation | 1 | 2021 | 59 | 0.180 |
Why?
|
Orthopedic Procedures | 2 | 2021 | 1280 | 0.180 |
Why?
|
United States | 16 | 2024 | 72903 | 0.180 |
Why?
|
Hospitalization | 5 | 2024 | 10808 | 0.180 |
Why?
|
Efficiency, Organizational | 2 | 2016 | 697 | 0.180 |
Why?
|
Diabetes Mellitus | 5 | 2018 | 5891 | 0.180 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2020 | 42 | 0.180 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12509 | 0.180 |
Why?
|
Cross-Sectional Studies | 11 | 2023 | 26318 | 0.180 |
Why?
|
Pain | 6 | 2020 | 5077 | 0.170 |
Why?
|
Employment | 3 | 2006 | 1106 | 0.170 |
Why?
|
Emigrants and Immigrants | 2 | 2016 | 549 | 0.170 |
Why?
|
Receptors, Serotonin | 1 | 2020 | 210 | 0.160 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2022 | 2176 | 0.160 |
Why?
|
Academic Medical Centers | 5 | 2018 | 2780 | 0.160 |
Why?
|
Pleurisy | 1 | 1999 | 53 | 0.160 |
Why?
|
Longitudinal Studies | 7 | 2019 | 14751 | 0.160 |
Why?
|
Poverty | 3 | 2016 | 2714 | 0.160 |
Why?
|
Cost-Benefit Analysis | 9 | 2022 | 5526 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 219 | 0.160 |
Why?
|
Biological Transport | 1 | 2023 | 2081 | 0.150 |
Why?
|
Emergency Service, Hospital | 4 | 2015 | 7875 | 0.150 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2334 | 0.150 |
Why?
|
Attitude of Health Personnel | 3 | 2012 | 3925 | 0.150 |
Why?
|
Hyperlipidemias | 2 | 2015 | 770 | 0.150 |
Why?
|
Pneumonia, Bacterial | 1 | 2001 | 318 | 0.150 |
Why?
|
Osteoarthritis, Knee | 2 | 2020 | 1248 | 0.150 |
Why?
|
Logistic Models | 7 | 2014 | 13266 | 0.150 |
Why?
|
Anti-Infective Agents | 1 | 2006 | 986 | 0.150 |
Why?
|
Back | 1 | 2018 | 65 | 0.150 |
Why?
|
Risk Factors | 14 | 2024 | 74840 | 0.150 |
Why?
|
Exercise Movement Techniques | 1 | 2017 | 10 | 0.150 |
Why?
|
Critical Pathways | 1 | 2001 | 474 | 0.140 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2020 | 331 | 0.140 |
Why?
|
Antidepressive Agents | 2 | 2020 | 2897 | 0.140 |
Why?
|
Secondary Prevention | 1 | 2024 | 1472 | 0.140 |
Why?
|
Bed Rest | 1 | 1997 | 82 | 0.140 |
Why?
|
Aftercare | 1 | 2023 | 911 | 0.140 |
Why?
|
Electronic Prescribing | 1 | 2018 | 115 | 0.140 |
Why?
|
Angina Pectoris | 1 | 2021 | 956 | 0.140 |
Why?
|
Patient Participation | 3 | 2024 | 1455 | 0.140 |
Why?
|
Lumbosacral Region | 2 | 2017 | 295 | 0.140 |
Why?
|
Affect | 2 | 2020 | 1500 | 0.140 |
Why?
|
Point-of-Care Systems | 1 | 2005 | 1217 | 0.130 |
Why?
|
Mental Disorders | 2 | 2013 | 6853 | 0.130 |
Why?
|
Incidence | 8 | 2024 | 21480 | 0.130 |
Why?
|
Pain, Postoperative | 1 | 2006 | 1772 | 0.130 |
Why?
|
Health Status | 3 | 2015 | 4080 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2018 | 4058 | 0.130 |
Why?
|
Cluster Analysis | 2 | 2015 | 2721 | 0.130 |
Why?
|
Continuity of Patient Care | 3 | 2016 | 1078 | 0.130 |
Why?
|
Minority Health | 1 | 2016 | 79 | 0.120 |
Why?
|
Muscle Strength | 1 | 2020 | 637 | 0.120 |
Why?
|
Patients | 3 | 2012 | 910 | 0.120 |
Why?
|
Pneumonia | 4 | 2000 | 2157 | 0.120 |
Why?
|
Office Visits | 1 | 2019 | 595 | 0.120 |
Why?
|
Health Services for the Aged | 1 | 2017 | 265 | 0.120 |
Why?
|
Dermatitis, Atopic | 1 | 2022 | 729 | 0.110 |
Why?
|
Urban Population | 2 | 2015 | 2040 | 0.110 |
Why?
|
Focus Groups | 2 | 2014 | 1459 | 0.110 |
Why?
|
Postnatal Care | 1 | 2016 | 275 | 0.110 |
Why?
|
Physical Therapy Modalities | 1 | 2017 | 533 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 416 | 0.110 |
Why?
|
Operations Research | 1 | 2013 | 23 | 0.110 |
Why?
|
Ketamine | 1 | 2020 | 525 | 0.110 |
Why?
|
Costs and Cost Analysis | 2 | 2018 | 1668 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1060 | 0.110 |
Why?
|
Spine | 1 | 2020 | 1128 | 0.110 |
Why?
|
Multilingualism | 1 | 2014 | 86 | 0.110 |
Why?
|
Blood Glucose | 3 | 2018 | 6424 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 521 | 0.100 |
Why?
|
Delphi Technique | 1 | 2017 | 893 | 0.100 |
Why?
|
Anxiety | 3 | 2017 | 4671 | 0.100 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15398 | 0.100 |
Why?
|
Papillomaviridae | 3 | 2025 | 1141 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 953 | 0.100 |
Why?
|
Boston | 4 | 2020 | 9338 | 0.100 |
Why?
|
Administration, Oral | 2 | 2018 | 4015 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 20659 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1999 | 838 | 0.100 |
Why?
|
Practice Management, Medical | 1 | 2014 | 191 | 0.100 |
Why?
|
Cooperative Behavior | 2 | 2016 | 1509 | 0.100 |
Why?
|
Reproducibility of Results | 7 | 2023 | 20124 | 0.100 |
Why?
|
Medically Underserved Area | 1 | 2014 | 266 | 0.100 |
Why?
|
Public Health Administration | 1 | 2015 | 241 | 0.100 |
Why?
|
Health Literacy | 2 | 2017 | 464 | 0.100 |
Why?
|
Survival Rate | 4 | 2021 | 12795 | 0.100 |
Why?
|
Patient Care Team | 2 | 2016 | 2517 | 0.100 |
Why?
|
Heart Rate | 1 | 2023 | 4204 | 0.090 |
Why?
|
Photoplethysmography | 2 | 2022 | 66 | 0.090 |
Why?
|
Hospitals, Urban | 1 | 2013 | 493 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2001 | 2172 | 0.090 |
Why?
|
Acute Disease | 4 | 2007 | 7232 | 0.090 |
Why?
|
Comorbidity | 3 | 2016 | 10563 | 0.090 |
Why?
|
Maternal Health Services | 1 | 2016 | 472 | 0.090 |
Why?
|
Appointments and Schedules | 1 | 2015 | 444 | 0.090 |
Why?
|
Patient Care | 1 | 2016 | 629 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 3 | 2022 | 1737 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 805 | 0.090 |
Why?
|
Educational Status | 2 | 2015 | 2513 | 0.090 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1238 | 0.090 |
Why?
|
Leg | 2 | 2005 | 1080 | 0.080 |
Why?
|
Workload | 1 | 2015 | 851 | 0.080 |
Why?
|
Orthopedics | 1 | 2018 | 900 | 0.080 |
Why?
|
Health Surveys | 2 | 2018 | 4056 | 0.080 |
Why?
|
Biomedical Research | 1 | 2005 | 3458 | 0.080 |
Why?
|
Patient Compliance | 2 | 2017 | 2692 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2016 | 1315 | 0.080 |
Why?
|
Research Design | 2 | 2021 | 6209 | 0.080 |
Why?
|
Muscle Relaxants, Central | 1 | 2010 | 94 | 0.080 |
Why?
|
Prenatal Care | 1 | 2016 | 1160 | 0.080 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6544 | 0.080 |
Why?
|
Particulate Matter | 1 | 2021 | 2624 | 0.080 |
Why?
|
Mitral Valve | 1 | 2017 | 1476 | 0.080 |
Why?
|
Deoxy Sugars | 1 | 1988 | 17 | 0.080 |
Why?
|
Ambulatory Care | 2 | 2005 | 2778 | 0.080 |
Why?
|
Hypoglycemia | 1 | 2015 | 896 | 0.080 |
Why?
|
Halothane | 1 | 1988 | 200 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2023 | 14652 | 0.070 |
Why?
|
Delivery of Health Care | 5 | 2023 | 5370 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2020 | 1732 | 0.070 |
Why?
|
Narcotics | 1 | 2010 | 332 | 0.070 |
Why?
|
Mitral Valve Insufficiency | 1 | 2017 | 1414 | 0.070 |
Why?
|
Deoxyglucose | 1 | 1988 | 321 | 0.070 |
Why?
|
Qualitative Research | 1 | 2018 | 3139 | 0.070 |
Why?
|
Anesthesia, Inhalation | 1 | 1988 | 216 | 0.070 |
Why?
|
Blood Transfusion | 1 | 1994 | 1297 | 0.070 |
Why?
|
Attitude to Health | 2 | 2019 | 2020 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2535 | 0.070 |
Why?
|
GTP Cyclohydrolase | 1 | 2006 | 47 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2021 | 10383 | 0.070 |
Why?
|
Poverty Areas | 1 | 2008 | 268 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4958 | 0.070 |
Why?
|
Adolescent | 12 | 2020 | 88835 | 0.070 |
Why?
|
Young Adult | 7 | 2025 | 59889 | 0.070 |
Why?
|
Heart Failure | 2 | 2021 | 11840 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10729 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2021 | 4544 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12056 | 0.060 |
Why?
|
Ambulatory Care Information Systems | 1 | 2005 | 89 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2203 | 0.060 |
Why?
|
Clinical Competence | 2 | 2024 | 4863 | 0.060 |
Why?
|
Models, Theoretical | 2 | 2015 | 3564 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 2 | 2008 | 1195 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6203 | 0.060 |
Why?
|
Prevalence | 3 | 2023 | 15842 | 0.060 |
Why?
|
Cultural Competency | 1 | 2008 | 303 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9249 | 0.060 |
Why?
|
Echocardiography | 1 | 2017 | 5045 | 0.060 |
Why?
|
Disabled Persons | 2 | 2006 | 1208 | 0.060 |
Why?
|
Odds Ratio | 2 | 2017 | 9649 | 0.060 |
Why?
|
Telemedicine | 2 | 2021 | 3105 | 0.060 |
Why?
|
Perception | 1 | 2010 | 1205 | 0.050 |
Why?
|
Patient Preference | 2 | 2023 | 952 | 0.050 |
Why?
|
Texas | 1 | 2025 | 410 | 0.050 |
Why?
|
Depression | 2 | 2017 | 8237 | 0.050 |
Why?
|
Streptococcus pyogenes | 1 | 2005 | 295 | 0.050 |
Why?
|
Health Services | 1 | 2008 | 756 | 0.050 |
Why?
|
Registries | 3 | 2020 | 8297 | 0.050 |
Why?
|
Pain Threshold | 1 | 2006 | 604 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3242 | 0.050 |
Why?
|
Activities of Daily Living | 3 | 2007 | 2415 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1405 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2007 | 1731 | 0.050 |
Why?
|
Complementary Therapies | 2 | 2021 | 487 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2017 | 4533 | 0.050 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 325 | 0.050 |
Why?
|
Endpoint Determination | 1 | 2004 | 591 | 0.050 |
Why?
|
Insurance, Health | 1 | 2014 | 2521 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6599 | 0.050 |
Why?
|
Fear | 1 | 2010 | 1499 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5302 | 0.050 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2025 | 392 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 1806 | 0.040 |
Why?
|
Movement | 1 | 2007 | 1462 | 0.040 |
Why?
|
Software | 1 | 2014 | 4462 | 0.040 |
Why?
|
Bacteriological Techniques | 1 | 2001 | 276 | 0.040 |
Why?
|
Postoperative Period | 1 | 2005 | 1816 | 0.040 |
Why?
|
Spinal Cord | 1 | 1988 | 1784 | 0.040 |
Why?
|
Hemorrhage | 2 | 2022 | 3461 | 0.040 |
Why?
|
Drug Resistance | 1 | 2006 | 1591 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6255 | 0.040 |
Why?
|
Age Factors | 3 | 2016 | 18380 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13648 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3446 | 0.040 |
Why?
|
Blood | 1 | 2001 | 597 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 761 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 314 | 0.040 |
Why?
|
Attitude | 1 | 2023 | 770 | 0.040 |
Why?
|
Automation | 1 | 2020 | 585 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2009 | 2074 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 482 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3529 | 0.040 |
Why?
|
Otolaryngology | 1 | 2005 | 698 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4255 | 0.040 |
Why?
|
Recurrence | 2 | 2020 | 8501 | 0.040 |
Why?
|
Motor Activity | 1 | 2007 | 2704 | 0.030 |
Why?
|
Health Behavior | 1 | 2009 | 2650 | 0.030 |
Why?
|
ROC Curve | 2 | 2020 | 3620 | 0.030 |
Why?
|
Aerosols | 1 | 2020 | 633 | 0.030 |
Why?
|
Models, Economic | 1 | 2021 | 716 | 0.030 |
Why?
|
Bhutan | 1 | 2016 | 61 | 0.030 |
Why?
|
Morbidity | 2 | 2019 | 1749 | 0.030 |
Why?
|
Pain Measurement | 3 | 2020 | 3561 | 0.030 |
Why?
|
Quebec | 1 | 1996 | 140 | 0.030 |
Why?
|
Iraq | 1 | 2016 | 93 | 0.030 |
Why?
|
Confidentiality | 1 | 2021 | 607 | 0.030 |
Why?
|
Somalia | 1 | 2016 | 78 | 0.030 |
Why?
|
Forecasting | 2 | 2015 | 2936 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 8041 | 0.030 |
Why?
|
Counseling | 1 | 2024 | 1551 | 0.030 |
Why?
|
Absenteeism | 1 | 1997 | 246 | 0.030 |
Why?
|
Policy Making | 1 | 2020 | 546 | 0.030 |
Why?
|
Utilization Review | 1 | 2017 | 381 | 0.030 |
Why?
|
Geography | 1 | 2018 | 652 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 814 | 0.030 |
Why?
|
Endoscopy | 1 | 2005 | 1841 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2005 | 7478 | 0.030 |
Why?
|
Benzamides | 1 | 2020 | 1377 | 0.030 |
Why?
|
Seasons | 1 | 2021 | 1524 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2006 | 2737 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 845 | 0.030 |
Why?
|
Reoperation | 1 | 2005 | 4294 | 0.030 |
Why?
|
Bucladesine | 1 | 1994 | 117 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2020 | 714 | 0.030 |
Why?
|
Pyrroles | 1 | 2020 | 1119 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2226 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 1999 | 3432 | 0.030 |
Why?
|
Blood Transfusion, Autologous | 1 | 1994 | 123 | 0.030 |
Why?
|
Inservice Training | 1 | 2016 | 375 | 0.030 |
Why?
|
Ovulation | 1 | 1994 | 178 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2006 | 3714 | 0.030 |
Why?
|
Independent Living | 1 | 2017 | 585 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5876 | 0.030 |
Why?
|
Food | 1 | 2018 | 764 | 0.030 |
Why?
|
Prostaglandins | 1 | 1994 | 396 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 802 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2016 | 596 | 0.030 |
Why?
|
Adrenalectomy | 1 | 1994 | 344 | 0.030 |
Why?
|
Hematocrit | 1 | 1994 | 621 | 0.030 |
Why?
|
Patient Admission | 1 | 2000 | 1365 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16721 | 0.020 |
Why?
|
Frail Elderly | 1 | 2017 | 785 | 0.020 |
Why?
|
Chorionic Gonadotropin | 1 | 1994 | 457 | 0.020 |
Why?
|
Piperidines | 1 | 2020 | 1664 | 0.020 |
Why?
|
Glycemic Index | 1 | 2014 | 400 | 0.020 |
Why?
|
Hyperaldosteronism | 1 | 1994 | 252 | 0.020 |
Why?
|
Databases, Factual | 2 | 2020 | 8067 | 0.020 |
Why?
|
Group Practice | 1 | 2012 | 149 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 2268 | 0.020 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 2010 | 30 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2018 | 1051 | 0.020 |
Why?
|
Haplotypes | 2 | 2007 | 2728 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2018 | 1741 | 0.020 |
Why?
|
Walking | 1 | 2017 | 1198 | 0.020 |
Why?
|
Palliative Care | 1 | 2005 | 3645 | 0.020 |
Why?
|
Radiography | 1 | 2001 | 6919 | 0.020 |
Why?
|
Oxygen | 1 | 2001 | 4241 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2020 | 1416 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2020 | 1379 | 0.020 |
Why?
|
Rats, Inbred Strains | 2 | 1988 | 2077 | 0.020 |
Why?
|
Gene Frequency | 2 | 2007 | 3624 | 0.020 |
Why?
|
Ovary | 1 | 1994 | 956 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1968 | 0.020 |
Why?
|
Recovery of Function | 1 | 1999 | 2966 | 0.020 |
Why?
|
Health Policy | 1 | 2022 | 2698 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1998 | 1393 | 0.020 |
Why?
|
Physician Incentive Plans | 1 | 2010 | 165 | 0.020 |
Why?
|
Drug Therapy | 1 | 2012 | 504 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2888 | 0.020 |
Why?
|
Community Networks | 1 | 2010 | 203 | 0.020 |
Why?
|
Cerebral Ventricles | 1 | 1991 | 549 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2015 | 869 | 0.020 |
Why?
|
Fibroma | 1 | 1990 | 197 | 0.020 |
Why?
|
Hip Prosthesis | 1 | 1994 | 895 | 0.020 |
Why?
|
Orbital Neoplasms | 1 | 1990 | 223 | 0.020 |
Why?
|
Length of Stay | 1 | 2001 | 6485 | 0.020 |
Why?
|
Sepsis | 1 | 2001 | 2606 | 0.020 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2007 | 64 | 0.020 |
Why?
|
Injections, Epidural | 1 | 2009 | 204 | 0.020 |
Why?
|
Brain | 3 | 1991 | 27171 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 1988 | 543 | 0.020 |
Why?
|
Naproxen | 1 | 2007 | 99 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8733 | 0.020 |
Why?
|
Tramadol | 1 | 2007 | 63 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4752 | 0.020 |
Why?
|
Receptor, Galanin, Type 2 | 1 | 2006 | 2 | 0.020 |
Why?
|
Alcohol Oxidoreductases | 1 | 2006 | 164 | 0.020 |
Why?
|
Glucosephosphates | 1 | 1985 | 19 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2018 | 3212 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 1985 | 70 | 0.020 |
Why?
|
Medically Uninsured | 1 | 2010 | 838 | 0.010 |
Why?
|
Receptors, Opioid, mu | 1 | 2006 | 165 | 0.010 |
Why?
|
Prognosis | 2 | 2024 | 29922 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 18071 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6823 | 0.010 |
Why?
|
Medicine | 1 | 2012 | 942 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10033 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2009 | 1441 | 0.010 |
Why?
|
Electric Stimulation Therapy | 1 | 2009 | 635 | 0.010 |
Why?
|
Morphine | 1 | 2007 | 660 | 0.010 |
Why?
|
Receptors, GABA-A | 1 | 2007 | 624 | 0.010 |
Why?
|
Rats | 3 | 2006 | 23707 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1775 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8703 | 0.010 |
Why?
|
Nerve Block | 1 | 2009 | 715 | 0.010 |
Why?
|
Genotype | 2 | 2007 | 13024 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36386 | 0.010 |
Why?
|
Social Class | 1 | 2010 | 2007 | 0.010 |
Why?
|
Area Under Curve | 1 | 2005 | 1638 | 0.010 |
Why?
|
Language | 1 | 2010 | 1550 | 0.010 |
Why?
|
Medicaid | 1 | 2014 | 2833 | 0.010 |
Why?
|
Psychotropic Drugs | 1 | 2006 | 879 | 0.010 |
Why?
|
Case-Control Studies | 1 | 1998 | 22223 | 0.010 |
Why?
|
Societies, Medical | 1 | 2011 | 3956 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4108 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23601 | 0.010 |
Why?
|
New York | 1 | 2000 | 880 | 0.010 |
Why?
|
Alleles | 1 | 2007 | 6897 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3715 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2009 | 2788 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4247 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 1999 | 601 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11083 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 30260 | 0.010 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1994 | 80 | 0.010 |
Why?
|
Depression, Chemical | 1 | 1994 | 186 | 0.010 |
Why?
|
Medical Records | 1 | 2000 | 1409 | 0.010 |
Why?
|
Dinoprost | 1 | 1994 | 139 | 0.010 |
Why?
|
DNA | 1 | 2007 | 7202 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1994 | 860 | 0.010 |
Why?
|
Self Care | 1 | 1998 | 800 | 0.010 |
Why?
|
Genetic Testing | 1 | 2006 | 3595 | 0.010 |
Why?
|
Blood Pressure | 1 | 1988 | 8532 | 0.010 |
Why?
|
Schizophrenia | 1 | 1991 | 6972 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1994 | 558 | 0.010 |
Why?
|
Hyperplasia | 1 | 1994 | 1144 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 5089 | 0.010 |
Why?
|
Genetic Variation | 1 | 2006 | 6610 | 0.010 |
Why?
|
Health Status Indicators | 1 | 1995 | 966 | 0.010 |
Why?
|
Perfusion | 1 | 1994 | 1407 | 0.000 |
Why?
|
Animals | 4 | 2006 | 168764 | 0.000 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1994 | 730 | 0.000 |
Why?
|
Cerebrospinal Fluid | 1 | 1991 | 539 | 0.000 |
Why?
|
Rabbits | 1 | 1994 | 4734 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 16047 | 0.000 |
Why?
|
Risk | 1 | 2000 | 9591 | 0.000 |
Why?
|
Steroids | 1 | 1990 | 933 | 0.000 |
Why?
|
Adenoma | 1 | 1994 | 2152 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1994 | 2098 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1991 | 36532 | 0.000 |
Why?
|
Mutation | 1 | 2006 | 30198 | 0.000 |
Why?
|
Glycolysis | 1 | 1985 | 838 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1999 | 15747 | 0.000 |
Why?
|
Sex Factors | 1 | 1991 | 10603 | 0.000 |
Why?
|
Glucose | 1 | 1985 | 4335 | 0.000 |
Why?
|